Explore our newsroom for Symani press releases, news stories, and journalist resources.
Stay up to date with the latest Symani news
Subscribe for timely email updates from MMI
"*" indicates required fields
Medical Microinstruments S.p.A. Announces €20M in Series A Funding to Advance Its Robotic Platform for Microsurgery
EU backs MMI’s Robotic System for Microsurgery
MMI SpA Launches Breakthrough Technology, Advancing Robotic Microsurgery with the World’s Smallest Wristed Surgical Instruments
Medical Microinstruments Appoints Healthcare Industry Veteran Mark Toland as Chief Executive Officer
Medical Microinstruments’ Symani® Surgical System Saves Patient’s Arm from Amputation
Lymphovenous Anastomosis and Lymph Node Transfer Performed with Medical Microinstruments’ Symani® Surgical System at the Renowned University Hospital Zurich
Medical Microinstruments Announces Major Expansion in Pisa, Italy to Support Growth
Medical Microinstruments Launches New Simulator for Robotic Microsurgery
Medical Microinstruments Participates in the “Minimally Invasive Robotic Surgery Systems (TREMIRS)” Project
Medical Microinstruments Secures $75M to Advance Robotic Microsurgery
Medical Microinstruments to Present at the 41st Annual J.P. Morgan Healthcare Conference
Medical Microinstruments Introduces Even Smaller Robotic Instruments to Address Complex Supermicrosurgery
5022 Gate Parkway,
Building 500,
Jacksonville, FL 32256
The Symani Surgical System is authorized for use in the U.S. by the FDA and is a CE marked medical device. Clinical indications vary by geography. Refer to global indications for more information. © 2024 Medical Microinstruments, Inc. All Rights Reserved.